Objective:

To assess the relationship between vitamin D levels and specific indicators of bone disease, such as fracture risk and bone mineral density, in community-dwelling patients.

Key Findings:

• Many patients with low serum vitamin D levels do not show clear biochemical or structural indicators of bone disease, indicating a potential disconnect between vitamin D levels and bone health.
• Only about 6% of patients with 25(OH)D levels below 30 nmol/L had low serum calcium, and approximately 3% had low phosphate levels, suggesting limited biochemical abnormalities.
• Bone biopsy data and imaging studies did not consistently show associations between vitamin D levels and reduced bone mineral density, raising questions about the reliability of current deficiency thresholds.
• Mixed evidence on vitamin D supplementation for fracture prevention, with some studies showing no significant reduction in fracture risk, particularly in community-dwelling populations.

Interpretation:

The findings suggest that vitamin D deficiency may not be a reliable indicator of bone disease in community-dwelling patients, indicating a need to reevaluate the thresholds for deficiency and their clinical implications.

Limitations:

• The thresholds for vitamin D deficiency were not established based on clear evidence of bone disease, which may limit their applicability.
• Evidence from randomized controlled trials is mixed and may not apply to all populations, complicating the interpretation of supplementation efficacy.

Conclusion:

Widespread screening or supplementation for vitamin D in healthy community populations is not supported; instead, targeted approaches for high-risk groups, such as those with limited sun exposure or malnutrition, are recommended.